Andrea Charles | 06/17/2013
The FDA Final Rule on UDIs is a critical move forward in utilising and leveraging technology to advance medical device information. In this exclusive interview Dawn Fowler, Sr. Manager, Labeling & Documentation at Endologix, speaks to Andrea Charles from Pharma IQ, about the importance of real world assessment in executing UDI programs and reveals scalable ways to implement unique identifiers for medical devices. Fowler also shares her top 3 tips for implementing UDI Information...
To continue reading this story Click Here
Upcoming Events
DigIT Pharma 2026 | AI Commercial, Medical & Patient Care
September 9 - 10, 2026
Berlin, Germany
Register Now |
View Agenda |
Learn More
Pharmaceutical Launch Excellence Summit US
September 30 - October 1 2026
Hyatt Regency Boston Harbor, Boston, US
Register Now |
View Agenda |
Learn More